New lupus drug begins first human safety tests
Disease control
Not yet recruiting
This is an early-stage study to check the safety and side effects of a new injection called HC022 in people with lupus. Researchers will give different doses to 32 adult volunteers with lupus to see how their bodies handle the drug and to look for any problems. The main goal is t…
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC